Antiretroviral therapy in HIV-infected adults. Which regimens are recommended?
Lancaster, D.J.; Lancaster, L.L.
Postgraduate Medicine 95(1): 47-50 53-5
1994
ISSN/ISBN: 0032-5481 PMID: 7904062 Document Number: 431167
The current status of antiretroviral therapy is in a state of flux. Clinical and immunologic benefit of antiretroviral treatment has been demonstrated, but the duration of benefit is finite and the effect on survival uncertain. Failure of antiretroviral treatment is closely associated with development of drug resistance. Strategies that may improve treatment outcome include combining or cycling antiretroviral agents. Given the current uncertainties in antiretroviral therapy, patients should be actively involved in treatment decisions.
Document emailed within 1 workday
Related Documents
Auld, A.F.; Agolory, S.G.; Shiraishi, R.W.; Wabwire-Mangen, F.; Kwesigabo, G.; Mulenga, M.; Hachizovu, S.; Asadu, E.; Tuho, M.Zanga.; Ettiegne-Traore, V.; Mbofana, F.; Okello, V.; Azih, C.; Denison, J.A.; Tsui, S.; Koole, O.; Kamiru, H.; Nuwagaba-Biribonwoha, H.; Alfredo, C.; Jobarteh, K.; Odafe, S.; Onotu, D.; Ekra, K.A.; Kouakou, J.S.; Ehrenkranz, P.; Bicego, G.; Torpey, K.; Mukadi, Y.Diul.; van Praag, E.; Menten, J.; Mastro, T.; Dukes Hamilton, C.; Swaminathan, M.; Dokubo, E.Kainne.; Baughman, A.L.; Spira, T.; Colebunders, R.; Bangsberg, D.; Marlink, R 2014: Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013 MMWR. Morbidity and mortality weekly report 63(47): 1097-1103Katz, I.T.; Essien, T.; Marinda, E.T.; Gray, G.E.; Bangsberg, D.R.; Martinson, N.A.; De Bruyn, G. 2011: Antiretroviral therapy refusal among newly diagnosed HIV-infected adults Aids 25(17): 2177-2181
Manosuthi, W.; Ongwandee, S.; Bhakeecheep, S.; Leechawengwongs, M.; Ruxrungtham, K.; Phanuphak, P.; Hiransuthikul, N.; Ratanasuwan, W.; Chetchotisakd, P.; Tantisiriwat, W.; Kiertiburanakul, S.; Avihingsanon, A.; Sukkul, A.; Anekthananon, T. 2015: Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand Aids Research and Therapy 12: 12
Page, I.D.; McKew, S.J.; Kudzala, A.G.; Fullwood, C.; van Oosterhout, J.J.; Bates, I. 2013: Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy International Journal of Std and Aids 24(6): 449-453
Mavura, D.R.; Masenga, E.J.; Minja, E.; Grossmann, H.; Crump, J.A.; Bartlett, J.A. 2015: Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania International Journal of Dermatology 54(1): 68-73
Rehman, A.M.; Woodd, S.; Chisenga, M.; Siame, J.; Sampson, G.; PrayGod, G.; Koethe, J.R.; Kelly, P.; Filteau, S. 2015: Appetite testing in HIV-infected African adults recovering from malnutrition and given antiretroviral therapy Public Health Nutrition 18(4): 742-751
Beaulière, A.; Touré, S.; Alexandre, P.-K.éb.; Koné, K.; Pouhé, A.; Kouadio, B.; Journy, N.; Son, J.ér.ôm.; Ettiègne-Traoré, V.; Dabis, F.ço.; Eholié, S.; Anglaret, X. 2010: The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire Plos one 5(6): E11213
Bisson, G.P.; Gross, R.; Bellamy, S.; Chittams, J.; Hislop, M.; Regensberg, L.; Frank, I.; Maartens, G.; Nachega, J.B. 2008: Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy - Comparaison entre l'adhérence au renouvellement des médicaments et les changements dans le taux de CD4 pour le suivi du traitement antirétroviral chez des adultes atteints par le VIH Plos Medicine 5(5): 777-789
Siegfried, N.; Uthman, O.A.; Rutherford, G.W. 2010: Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults Cochrane Database of Systematic Reviews 3: Cd008272
Walker, A.S.; Prendergast, A.J.; Mugyenyi, P.; Munderi, P.; Hakim, J.; Kekitiinwa, A.; Katabira, E.; Gilks, C.F.; Kityo, C.; Nahirya-Ntege, P.; Nathoo, K.; Gibb, D.M.; Grosskurth, H.; Munderi, P.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Mugisha, A.; Todd, J.; Levin, J.; Muyingo, S.; Ruberantwari, A.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Lyagoba, F.; Hughes, P.; Aber, M.; Lara, A. M.; Foster, S.; Amurwon, J.; Wakholi, B. N.; Whitworth, J.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Fadhiru, K.; Nsibambi, D.; Khauka, P.; Mugyenyi, P.; Kityo, C.; Ssali, F.; Tumuku 2012: Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 55(12): 1707-1718
Bard, J-Marie.; Lassalle, Régis.; Capeau, J.; Bach-Ngohou, K.; Nazih-Sanderson, Fçoise.; Rémy, Gérard.; Reynes, J.; Ecobichon, J-Luc.; Savès, M.; Raffi, Fçois. 2006: Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy Antiviral Therapy 11(3): 361-370
Namutebi, A.M.N.; Kamya, M.R.K.; Byakika-Kibwika, P. 2013: Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda African Health Sciences 13(4): 977-985
Bisson, G.P.; Gross, R.; Bellamy, S.; Chittams, J.; Hislop, M.; Regensberg, L.; Frank, I.; Maartens, G.; Nachega, J.B. 2008: Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy Plos Medicine 5(5): e109
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Popoola, T.D.; Awodele, O.; Oshikoya, K.A. 2016: A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria African Journal of Medicine and Medical Sciences 45(2): 179-187
Anderson, K.; Muloiwa, R.; Davies, M.-A. 2018: Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after ≥10 years on antiretroviral therapy South African Medical Journal 109(1): 27-34
Raffi, F.; Reliquet, V.; Ferré, V.; Arvieux, C.; Hascoet, C.; Bellein, V.; Besnier, J.M.; Breux, J.P.; Garré, M.; May, T.; Molina, J.M.; Perré, P.; Raguin, G.; Rozenbaum, W.; Zucman, D. 2000: The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults Antiviral Therapy 5(4): 267-272
Sungkanuparph, S.; Anekthananon, T.; Hiransuthikul, N.; Bowonwatanuwong, C.; Supparatpinyo, K.; Mootsikapun, P.; Chetchotisakd, P.; Kiertiburanakul, S.; Tansuphaswadikul, S.; Buppanharun, W.; Manosuthi, W.; Techasathit, W.; Ratanasuwan, W.; Tantisiriwat, W.; Suwanagool, S.; Leechawengwongs, M.; Ruxrungtham, K. 2008: Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008 Journal of the Medical Association of Thailand 91(12): 1925-1935
Ezeamama, A.E.; Guwatudde, D.; Wang, M.; Bagenda, D.; Brown, K.; Kyeyune, R.; Smith, E.; Wamani, H.; Manabe, Y.C.; Fawzi, W.W. 2016: High perceived social standing is associated with better health in HIV-infected Ugandan adults on highly active antiretroviral therapy Journal of Behavioral Medicine 39(3): 453-464